SpeedWeed

MARCH 4, 2021

In the 2020 National Drug Threat Assessment , which was released by the DEA on Wednesday, the agency notes that despite its continued illegality under federal law, marijuana “is the most commonly used illicit drug in the United States.”. The DEA explains that in 2019, U.S. million kilograms were seized,” the DEA reports.

DEA 52

DEA Supply Chain Advocacy Recreational 52

Canna Law Blog

FEBRUARY 16, 2024

Griffen’s article is just one of many parsing the language of the 2018 Farm Bill and a 2023 DEA letter on the topic. See also: “ THCA and the DEA: Rod Breaks Down the Latest News ” from Rod Kight, an another attorney prominent in the space. I would say: “Someone over at DEA wrote a letter last year indicating that it’s not.

DEA 80

DEA Seed-To-Sale Hemp Concentrates 80

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

The Blunt Truth

DECEMBER 26, 2019

Welcome to The Week in Weed’s look back at the news of 2019; whether the year has flown by or seemed to last forever, it’s (almost) over now. Without further ado, here’s a look at the stories that grabbed our attention in 2019. Several northeastern states tried to coordinate their marijuana policies.

Banking 71

Banking Hemp Agriculture Seed-To-Sale 71

The Blunt Truth

AUGUST 1, 2019

In other federal news, the DEA has, yet again, not approved new suppliers of marijuana for research. And the new prime minister, Boris Johnson, has appointed a cannabis advocate as a policy adviser. There will have to be a bit more awaiting, it seems. A lawsuit is pending, so perhaps next year, things will be different.

DEA 77

DEA Banking Dispensary Edibles 77

NORML

JANUARY 17, 2019

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. . The agency ultimately rejected her decision.

Clinical Trials 232

Clinical Trials Legislation DEA Strains 232

Canna Law Blog

JULY 26, 2023

The whole thing crashed following the 2019 growing season, and a spate of lawsuits ran through the office. Bad policy and the new cannabinoids markets It always starts with policy. hemp policy The good news is the Farm Bill is renewed every five years. After the 2018 Farm Bill passed, though, the gold rush commenced.

Hemp 81

Hemp DEA THC Policy 81

Cannabis Law Report

MARCH 10, 2019

By Peter Becker on March 8, 2019. Lawmakers in Olympia are determined that 2019 will be better — Hector Castro, Director of Communications for the Washington State Department of Agriculture recently stated, “It makes sense to assist farmers to get seeds in the ground this season.”. AUTHOR: Peter Becker – Lane Powell.

Hemp 45

Hemp Seed-To-Sale Agriculture DEA 45

The Blunt Truth

OCTOBER 24, 2019

The 2019 edition of the Hemp and CBD Industry Factbook released figures that show retail sales of CBD topping $1 billion this year, and predicted that number could hit $10 billion by 2024. Circuit Court refuse to involve itself in the company’s fight with the DEA over cannabis research licenses.

Hemp 58

Hemp DEA CBD Topical 58

Cannabis Law Report

JANUARY 6, 2022

10, 2019, the church filed to become a 501(c)(3) organization with the IRS. It also filed a request for a religious exemption with the DEA a month later. By August 2019, the church had 20 members, according to the filing, but stopped holding ceremonies as of Aug. ” On Jan. Source: [link].

DEA 52

DEA Education Policy Law 52

Veriheal

JULY 29, 2021

Office of National Drug Control Policy defined that the medal “seemed to directly undercut our messages to young people that drug use undermines a child’s opportunities for success.” Fast forward to 2019 and the DEA unveiled eagerly anticipated plans for cannabis research.

DEA 98

DEA Cannabis Cannabinoids Sativa 98

Cannabis Law Report

MAY 29, 2022

In May 2019, Denver became the first city to decriminalize psilocybin, followed by Oakland, CA, Washington, D.C., In 2019, FDA approved Spravato (esketamine) nasal spray for treatment of depression in adults. [8] 8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. Times (Nov.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

NOVEMBER 4, 2021

Should President Biden wish to acknowledge the political, economic, and moral realities surrounding cannabis policy, and fulfill the promises he made on the campaign trail, this report lays out a clear roadmap for how to do so.”. We’re beyond that.”. The FDA Director role continues to be unfilled.

DEA 52

DEA Marijuana Decriminalization Data 52

Veriheal

NOVEMBER 6, 2023

Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. In 2019, HB 197 was introduced into the state legislature. states and the District of Columbia currently have legal cannabis, medical or recreational.

Legalization 117

Legalization Recreational THC CBD 117

Canna Law Blog

DECEMBER 4, 2019

Presently, the public comment period ends on December 30, 2019 and it is unclear whether the comment period will be extended. Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. 3% Total THC.

Hemp 69

Hemp DEA CBD THC 69

Canna Law Blog

OCTOBER 15, 2020

On the other side of the country our nation’s capital has its own ballot initiative on psychedelics, Initiative 81, formally known as the Entheogenic Plant and Fungus Policy Act of 2020. Psilocybin remains a Schedule 1 drug, meaning the DEA says it has a high likelihood of abuse and no accepted medical use – just like marijuana.

DEA 91

DEA Therapy Decriminalization Cultivation 91

Cannabis Law Report

OCTOBER 15, 2019

Young & Craig Simonsen on October 15, 2019. The move marked the first time the DEA removed any form of cannabis from Schedule I and was due to the FDA’s approval of Epidiolex, a non-synthetic cannabis-derived medicine used to treat severe epilepsy. Educating employees about CBD and zero tolerance policies.

THC 40

THC CBD DEA Policy 40

Veriheal

AUGUST 24, 2022

The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S. This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. city to do so.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Canna Law Blog

AUGUST 30, 2020

As we wrote back in early 2019, the prohibition on interference ONLY applied to hemp cultivated under the 2018 Farm Bill. To be fair, the USDA did issue an opinion in mid-2019 that stated that states/tribes could not prohibit the interstate transport of hemp produced under the 2014 Farm Bill.

Hemp 98

Hemp Agriculture Extraction THC 98

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances. Authors Tracy Gallegos and Neville M. Rescheduling cannabis will not necessarily facilitate clinical research.

Business 52

Business Policy Clinical Trials Research and Development 52

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Today, groups with a decade or less of experience advance policy and conversations alongside the veteran alliances of the movement. NORML acts as a resource for media on cannabis, as well as informs lawmakers, lobbies and other top officials regarding policy. The Drug Policy Alliance (DPA). The Drug Policy Alliance (DPA).

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

AUGUST 23, 2021

In testimony before the US Senate in July 2019, Dr. Amy Abernethy, Principal Deputy Commissioner at FDA, stated that the Agency recognizes the need for “regulatory clarity, particularly given the significant public interest in hemp products, and CBD in particular.” Who’s responsible for regulating CBD in pet products?

Pets 105

Pets Hemp CBD Food 105

Cannabis Info

SEPTEMBER 13, 2019

Then in 1905, missionaries in Manila spearheaded an anti-opium campaign , a thinly veiled attempt to expel Chinese immigrants (opium dens had already been banned in parts of the US, not because of public health policies, or clinical research, but because of racist scaremongering about the Chinese). criminal justice system.

DEA 45

DEA Policy Media Programs 45

Cannabis Law Report

JUNE 28, 2021

This led to a backlog of hemp from 2019 that was carried over to 2020, which was compounded by the effects of the global pandemic. The DEA hasn’t issued formal guidance on whether Delta-8-THC derived from hemp is a controlled substance under federal law.

Hemp 80

Hemp CBD Legalization Supply Chain 80

Cannabis Law Report

FEBRUARY 28, 2022

12, 2019), [link] [ [link] ]. Show More According to the Drug Enforcement Administration (DEA), Schedule I drugs have “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” 10, 2019), [link] [ [link] ]. Feduccia et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

The Blunt Truth

MARCH 10, 2020

Manufacturers are responsible for certifying records, including all product data, which includes, for example, information on formulation, labeling, and DEA Schedule. Still, given the FDA’s inability to produce guidance by the fall of 2019, any potential stay in litigation may last for some time. CBD Class Action Litigation.

CBD 99

CBD Topical Agriculture Food 99

Cannabis Law Report

FEBRUARY 25, 2019

In the early months of 2019, and after the recent passage of the 2018 Farm Bill, an increasing number of state and municipal agencies continue to pay close attention to hemp-derived CBD products, in some cases leaving products under siege by regulators. If you wish to re-publish this story please do so with following accreditation.

CBD 71

CBD Food Compliance Compliance 71

Canna Law Blog

JANUARY 11, 2022

The issue of enforcement or compliance is probably the biggest one most states face at the policy level. Last year, we noted that “Americans are now 19 times more likely to overdose on drugs and about 5 times more likely to be arrested for drugs than they were the year the DEA was created.” Yet, the illicit market is huge.

Compliance 77

Compliance Compliance State Laws DEA 77

Cannabis Law Report

SEPTEMBER 20, 2019

DEA increases the cannabis research quota. The Drug Enforcement Administration (DEA) announced annual quotas for the manufacture of controlled substances for research purposes, providing for 7,000 pounds of cannabis to be used in scientific studies. This represents a 30 percent increase from the 2019 cannabis quota.

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Info

JUNE 8, 2019

Anslinger was appointed to the Federal Bureau of Narcotics (which later became the DEA) in the 1930’s, leading to his dedicated work in criminalizing all drugs?—?particularly Evidently a fan of Nixon’s drug policy, the 40th US president Ronald Reagan once again declared a ‘War on Drugs’ in 1981. particularly marijuana. Ronald Reagan.

DEA 77

DEA Epilepsy Hemp Recreational 77

CannaMD

SEPTEMBER 10, 2020

Significantly higher numbers come from the Centers for Disease Control , which in 2019 reported that some 16% of pregnant women aged 18 to 44 years self-reported frequent to daily marijuana use. Further, both opponents and proponents of medical marijuana can cite individual studies supporting their chosen position.

Marijuana 59

Marijuana Therapy Data THC 59

CannaMD

SEPTEMBER 15, 2020

To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. The Florida Highway Patrol Policy Manual outlines these rights. SHORT ANSWER: Maybe.

Law 126

Law Marijuana Patients Treatment 126

Canna Law Blog

FEBRUARY 27, 2020

It was only three months ago, on November 25, 2019, that the FDA sent out a whopping 15 warning letters to companies selling CBD and issued a consumer update stating that CBD was dangerous and could harm people before they even knew the harm occurred. USDA Ditches DEA Registration. The DEA Registration was a big part of this.

Hemp 145

Hemp CBD DEA Agriculture 145

Canna Law Blog

MAY 7, 2020

Ole Miss got the cannabis study and research cultivation gig from the DEA (via a contract with the National Institute on Drug Abuse (NIDA)) in 1968. As of December 2019, there are only two patients on the coveted list and no new entrants are permitted.

DEA 70

DEA Research and Development Cultivation Supply Chain 70

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. That power is typically delegated to the DEA.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Family physicians have a vested interest in policies that advance and protect the health of their patients and the public. Marijuana Possession for Personal Use. Call to Action.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40